Spear Bio

BiotechnologySeries AWoburn, USspear.bio

Latest round

Series A

Last raised

Jul 2024

Total raised

$47M

Investors

5

About Spear Bio

Based in Massachusetts, US, and founded in 2021 by Peng Yin and CTO Dr.a. Spear Bio operates as a biotechnology company that focuses on the development of the next-generation ultrasensitive immunodiagnostics and proteomics platform-based on a breakthrough technology called successive proximity extension amplification reaction (SPEAR). In July 2024, Spear Bio, Inc. The company’s product line includes NAB-Sure™, an assay and commercial proof-of-concept for ultrasensitive quantification of SARS-Cov-2 neutralizing antibodies from challenging samples such as finger-stick dried blood spots (DBS) and nasal swabs. Spear Bio also develops ultrasensitive immunoassays for detecting and quantifying low-abundance proteins in small sample volumes. The company's technology is based on a novel amplification method with significantly higher sensitivity than traditional immunoassays.

Who invested in Spear Bio

5 investors across 2 rounds

See all investors in Spear Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jul 23, 2024

    Amount

    $45M

    Investors

    Locked

  2. Seed

    Oct 11, 2023

    Amount

    $2.4M

    Investors

    Locked

Questions about Spear Bio

Who invested in Spear Bio?

Spear Bio has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Spear Bio raised?

Spear Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Spear Bio last raise money?

Spear Bio's most recent round on record is a Series A, in Jul 2024.

What does Spear Bio do?

Based in Massachusetts, US, and founded in 2021 by Peng Yin and CTO Dr.

Where is Spear Bio headquartered?

Spear Bio is headquartered in Woburn, US.

Which VCs invest in companies like Spear Bio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Spear Bio's stage. Their profiles are linked below.

Raising like Spear Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.